Junya Sato

16PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersPreventative health careMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Transport properties and non-equilibrium processes
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 03, 2026
Timing of bone-modifying agent initiation and skeletal-related event risk in patients with bone metastases from solid tumors: a retrospective landmark and propensity score-matched analysis.

|Feb 09, 2026
Reducing the incidence of Clostridioides difficile infection through educational and antimicrobial stewardship interventions.

Hiroki Nagaoka, Yuma Morita, Tomonori Ohya

|Feb 07, 2026
Storage stability of hospital-prepared mianserin suppositories: evaluation of residual active ingredient content and bacteriological contamination under different storage conditions.

Rei Tanaka, Tomoe Ichikawa, Junya Sato

|Feb 05, 2026
Safety and Efficacy of Concomitant Administration of Nanoliposomal Irinotecan + 5-Fluorouracil/Levo-Leucovorin for Pancreatic Cancer.

Akane Wakabayashi, Rei Tanaka, Yurie Fukumuro

|Jan 16, 2026
Activated carbon adsorption sheets suppress volatilization of anticancer drugs excreted in urine, preventing environmental contamination and human exposure.

Junya Sato, Riho Kusakai, Sayaka Hori

|Dec 23, 2025
Timing of bone-modifying agents after bone metastasis diagnosis and time to first skeletal-related event: A systematic review and study-level correlation analysis.

Junya Sato, Tatsuki Ikeda, Satoru Nihei

Pageof 3

Frequent Collaborators

5 joint publications

Rei Tanaka

2 joint publications

Tatsuki Ikeda

2 joint publications

Satoru Nihei

2 joint publications

Kenzo Kudo